Category: Baxter InternationalSyndicate content

Baxter blows away Wall Street as renal sales surge in Q1

April 17, 2014 by Arezu Sarvestani

Baxter International's medical products division gets a major boost in the company's 1st quarter, pushing adjusted per-share earnings 9¢ above expectations.

Baxter blows away Wall Street with dialysis sales surge in Q1

Illinois healthcare titan Baxter (NYSE:BAX) isn't getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.

Baxter adds 30 jobs in Malta | Medtech personnel moves for the week of Apr. 7, 2014

April 9, 2014 by MassDevice

Here's a look at some of the top personnel stories for medical device companies this week.

Report: Baxter to add 30 jobs in Malta

April 2, 2014 by Arezu Sarvestani

Report: Baxter to add 30 jobs in Malta

Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.

Report: Baxter to add 30 jobs in Malta

April 2, 2014 by Arezu Sarvestani

Healthcare giant Baxter is slated to add 30 new jobs at a Malta facility, according to local reports.

Updated April 2, 2014, at 3:10 p.m. EST with comments from Baxter.

Report: Baxter to add 30 jobs in Malta

Malta regulators announced this week that healthcare titan Baxter (NYSE:BAX) plans to add 30 additional jobs in the country.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter reveals plans to split pharma, medical products businesses

March 27, 2014 by Brad Perriello

Baxter International says it plans to go the way of rivals Abbott and Covidien in splitting its pharmaceuticals and medical products businesses into separate companies.

Baxter reveals plans to split pharma, medical products businesses

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter dodges foreign bribery beef | MassDevice.com On Call

February 24, 2014 by Arezu Sarvestani

Federal regulators close an investigation into Baxter's Chinese operations without taking any action against the healthcare giant.

MassDevice.com On Call

MASSDEVICE ON CALL — Baxter (NYSE:BAX) closed the books on a federal bribery investigation after regulators dropped the probe without finding wrongdoing, the company announced.

FDA warns Baxter on HomeChoice dialysis system, infusion pump

February 21, 2014 by Brad Perriello

The FDA warns Baxter International about problems with its HomeChoice dialysis device and with drug infusion pumps made at a pair of plants.

FDA warns Baxter on HomeChoice dialysis system, infusion pump

The FDA sent warning letters to Baxter (NYSE:BAX) this year, flagging infractions at an Illinois plant where Baxter makes its HomeChoice dialysis device and at a California plant that makes drug infusion pumps.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp